Search Results - "Vuong, Dinh Thy Hao"
-
1
Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam
Published in Therapeutic advances in medical oncology (01-01-2024)“…Afatinib is indicated for advanced-stage non-small-cell lung cancer (NSCLC) with Epidermal Growth Factor Receptor (EGFR) and uncommon mutations. However,…”
Get full text
Journal Article -
2
A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam
Published in BMC cancer (05-02-2024)“…This study aimed to evaluate the efficacy and side effects of first-line afatinib treatment in a real-world setting in Vietnam. This retrospective study was…”
Get full text
Journal Article -
3
Cancer-associated Thrombosis in Vietnam: Literature Review and Expert Perspectives
Published in Journal of Applied Hematology (01-01-2024)“…Cancer-associated thrombosis (CAT) is a substantial burden and an emerging topic of great interest in Vietnam. The management of CAT is complex, with several…”
Get full text
Journal Article -
4
FOLFOXIRI for First-Line Treatment of Unresectable Colorectal Cancer with Liver Metastases in a Resource-Limited Setting
Published in Journal of gastrointestinal cancer (01-12-2025)“…Purpose FOLFOXIRI is a standard treatment for unresectable colorectal cancer (CRC) liver metastases. However, limited data exists on its safety and…”
Get full text
Journal Article -
5
Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World Study
Published in Asian Pacific journal of cancer prevention : APJCP (01-10-2024)“…Afatinib, a second-generation epidermal growth factor receptor(EGFR) tyrosine kinase, has proven effective for non-small-cell lung cancer (NSCLC) patients with…”
Get more information
Journal Article